Thrivent Financial for Lutherans Sells 1,032 Shares of Pediatrix Medical Group, Inc. (NYSE:MD)

Thrivent Financial for Lutherans lowered its position in Pediatrix Medical Group, Inc. (NYSE:MD) by 1.6% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 65,475 shares of the company’s stock after selling 1,032 shares during the period. Thrivent Financial for Lutherans owned 0.08% of Pediatrix Medical Group worth $859,000 at the end of the most recent reporting period.

A number of other institutional investors also recently modified their holdings of the company. Parkside Financial Bank & Trust increased its holdings in Pediatrix Medical Group by 36.1% during the 4th quarter. Parkside Financial Bank & Trust now owns 3,919 shares of the company’s stock valued at $51,000 after purchasing an additional 1,040 shares in the last quarter. Quarry LP grew its holdings in shares of Pediatrix Medical Group by 54.1% during the third quarter. Quarry LP now owns 4,735 shares of the company’s stock worth $55,000 after purchasing an additional 1,662 shares during the last quarter. AlphaQuest LLC increased its stake in shares of Pediatrix Medical Group by 65.9% in the fourth quarter. AlphaQuest LLC now owns 5,066 shares of the company’s stock valued at $66,000 after buying an additional 2,012 shares in the last quarter. Smartleaf Asset Management LLC raised its holdings in shares of Pediatrix Medical Group by 750.9% in the fourth quarter. Smartleaf Asset Management LLC now owns 6,901 shares of the company’s stock valued at $91,000 after buying an additional 6,090 shares during the last quarter. Finally, FMR LLC raised its holdings in shares of Pediatrix Medical Group by 220.6% in the third quarter. FMR LLC now owns 9,841 shares of the company’s stock valued at $114,000 after buying an additional 6,771 shares during the last quarter. Institutional investors own 97.71% of the company’s stock.

Pediatrix Medical Group Stock Performance

MD stock opened at $14.50 on Wednesday. Pediatrix Medical Group, Inc. has a 1-year low of $6.62 and a 1-year high of $17.67. The company has a current ratio of 1.60, a quick ratio of 1.42 and a debt-to-equity ratio of 0.81. The firm has a market cap of $1.24 billion, a PE ratio of -12.09, a P/E/G ratio of 1.74 and a beta of 1.49. The business’s 50-day moving average price is $14.42 and its two-hundred day moving average price is $13.74.

Pediatrix Medical Group (NYSE:MD) last released its quarterly earnings data on Thursday, February 20th. The company reported $0.49 earnings per share for the quarter, beating the consensus estimate of $0.37 by $0.12. Pediatrix Medical Group had a positive return on equity of 15.47% and a negative net margin of 4.92%. The business had revenue of $502.36 million for the quarter, compared to analysts’ expectations of $486.22 million. As a group, research analysts forecast that Pediatrix Medical Group, Inc. will post 1.38 earnings per share for the current year.

Analyst Upgrades and Downgrades

A number of brokerages have weighed in on MD. Macquarie began coverage on shares of Pediatrix Medical Group in a research note on Monday, December 16th. They issued an “outperform” rating and a $18.00 target price for the company. StockNews.com upgraded shares of Pediatrix Medical Group from a “hold” rating to a “buy” rating in a research report on Wednesday, January 22nd. UBS Group increased their price objective on Pediatrix Medical Group from $16.50 to $18.50 and gave the company a “neutral” rating in a research report on Friday, February 21st. Finally, Truist Financial boosted their target price on Pediatrix Medical Group from $15.00 to $18.00 and gave the stock a “hold” rating in a research report on Friday, February 21st. Four investment analysts have rated the stock with a hold rating and three have assigned a buy rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of “Hold” and a consensus price target of $17.08.

Pediatrix Medical Group Company Profile

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.